Immuneering Inc. - Wutah bathi EPS kuartalan IMRX

Logo korporat perusahaan Immuneering (IMRX)

Immuneering Corporation (IMRX) is scaling its portfolio of targeted inhibitors by developing AI-driven software tools. This activity leverages a biopharmaceutical ecosystem for cellular pathway modeling to create precision drugs. Simultaneously, the company is implementing green chemistry principles and energy efficiency. The growth rate of quarterly earnings per share illustrates the current trend, where the value of the indicator is 0.90.

Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan immuneering.com (IMRX): kanggo periode 04.07.2022 - 17.11.2026

Rincian analitis perusahaan Immuneering Corporation

- rega saham lan konsensus proyeksi valuasi:
Pambiji fundamental perusahaan:immuneering.com - IMRX
Barang unggulan immuneering.com

Quarterly EPS growth measures the trend of net income per share relative to previous periods. This metric reveals a business's ability to generate income amid market volatility. By analyzing the quarterly EPS change, an investor assesses the stability of the company's capital. For Immuneering Corporation (IMRX), this indicator reflects the efficiency of managing costs for expensive R&D research. The stability of these figures confirms the security of current resources during the development of solid tumor therapies.

Analisis perusahaan pesaing

GMAB (Genmab) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|EXEL: Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|NUVL (Nuvalent Therapeutics) - Wutah bathi EPS kuartalan|Wutah bathi EPS kuartalan kymeratx.com|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan IDEAYA Biosciences, Inc. (IDYA)|ELVN (Enliven Therapeutics, Inc.) - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan ORIC (ORIC Pharmaceuticals Inc)|Wutah bathi resik saben saham sajroning taun lumaku Relay Pharma|Nurix Therapeutics Inc - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Tyra Biosciences|VSTM (Verastem, Inc.) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|GLUE: Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|CGEM (cullinanoncology.com) - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan C4 Tx CCCC|Wutah bathi EPS kuartalan BDTX|Repare Therapeutics Inc. - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|PMV Pharmaceuticals, Inc. - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan KPTI|PPCB: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Cyclacel Pharmaceuticals - Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|AADI: Wutah bathi EPS kuartalan|Aileron Therapeutics Inc - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|BPMC (Blueprint Medicines Corp.) - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan glycomimetics.com GLYC|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan SpringWorks (SWTX)